Melvin L.K. Chua: Understanding Clinical and Biological Heterogeneity is Key in Nasopharyngeal Carcinoma
Melvin LK CHUA/cancertherapyadvisor.com

Melvin L.K. Chua: Understanding Clinical and Biological Heterogeneity is Key in Nasopharyngeal Carcinoma

Melvin L.K. Chua, Professor at Duke-NUS Medical School, Head of Department of Head Neck and Thoracic Cancers at National Cancer Center Singapore, shared on LinkedIn:

“Not often do we get surgeons radiation oncologists and medical oncologists together for a sharing Masterclass on Nasopharyngeal Carcinoma (NPC) supposed by TopAlliance Biosciences Inc.

Excellent lectures on what’s in the horizon by Dr. James Chow, Prof. Darren Wan-Teck Lim

Case discussions by Prof. Dora Kwong.

Bottomline: Understanding Clinical and Biological Heterogeneity is key in NPC.”

Melvin L.K. Chua

Other articles about Melvin L.K. Chua on OncoDaily.